INNV — Innovage Holding Corp.

InnovAge Holding Corp. (INNV) Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenues: $239.7 million, up 14.7% year-over-year (YoY) from $209 million.
• Adjusted EBITDA: $22.2 million, significantly improved from $5.9 million YoY, with an adjusted EBITDA margin of 9.2%.
• Net Income: $11.8 million, compared to a net loss of $13.5 million in the prior year.
• Census Growth: Approximately 8,010 participants served, a 7.1% increase YoY, with 23,960 member months, up 7.9% YoY.
• Central Level Contribution Margin: $52.8 million, representing 22% of revenue, an increase from 17.7% YoY.
• Cash Position: $83.2 million in cash and cash equivalents, with total debt at $69.9 million.

2. Strategic Updates and Business Highlights

• Operational Improvements: Enhanced revenue integrity and Medicaid eligibility processes led to reduced revenue reserves and reinstated coverage for participants.
• Cost Management: Effective medical cost management through proactive care coordination and improved operational efficiency.
• Governance Changes: Tom Scully returned as chairman, with new board members added to strengthen oversight and alignment.
• Focus on Participant Experience: Initiatives aimed at improving onboarding, service recovery, and addressing grievances to enhance participant satisfaction and retention.

3. Forward Guidance and Outlook

• Revised Full-Year Guidance:
  • Member months expected between 92,900 and 95,700.
  • Total revenue projected between $925 million and $950 million.
  • Adjusted EBITDA forecasted between $70 million and $75 million.
• De Novo Losses: Anticipated to be in the range of $11.5 to $13.5 million for the fiscal year.

4. Bad News, Challenges, or Points of Concern

• Enrollment Variability: The company acknowledged potential challenges in enrollment during the third quarter, typically a softer period due to seasonal factors and flu season impacts.
• Disenrollment Rates: Although voluntary disenrollment is around 6% annually, there are concerns about higher-than-desired disenrollment rates in the early months of participant engagement.
• Regulatory Risks: Ongoing adjustments in Medicare and Medicaid rates and the impact of new legislation could affect future financial performance.

5. Notable Q&A Insights

• Margin Expectations: Analysts questioned the potential for back-half EBITDA margins, with management indicating a typical soft quarter in Q3 due to seasonal trends and flu impacts.
• Medicaid Redetermination Processes: Management highlighted improvements in internal processes for Medicaid eligibility, which have positively impacted revenue and member retention.
• Participant Experience Initiatives: Management discussed efforts to enhance the onboarding process and reduce voluntary disenrollments, emphasizing the importance of aligning participant expectations with their experiences.

Overall, InnovAge Holding Corp. reported strong financial performance in Q2 2026, driven by operational improvements and strategic initiatives, while also acknowledging challenges related to enrollment and regulatory dynamics. The company remains optimistic about its future outlook, supported by revised guidance reflecting better-than-expected performance.